Impact of Virtual Reality (e-Nature VR) During Hospitalization in Adult Intensive Care Unit
- Conditions
- Pain
- Interventions
- Behavioral: Intervention
- Registration Number
- NCT05617638
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Brief Summary
Randomized clinical trial to analyze the perceived impact of the virtual reality intervention on the experience of pain and well-being, and the influence on vital signs and the relationship with the length of stay in the intensive care unit.
- Detailed Description
The highly specialized and complex technology used in intensive care units to provide continuous monitoring of the patient health context makes possible to increase the survival of patients with critical and unstable clinical status, but increases the triggering factors of the stress of hospitalized patients. Staying in these therapy units is accompanied by additional stress, confusional mental states, cognitive dysfunction, and depression. Virtual reality is a technique that involves the use of computer technology to create the effect of an interactive three-dimensional world in which objects have a spatial presence reducing the suffering related to a medical procedure, without side effects and without the need for additional personnel. Actual exposure to nature can be difficult to achieve for patients admitted to intensive care. Therefore, exposure to nature via media devices, and virtual reality (VR) is considered a promising technology due to its advantage in creating a sense of immersion. Furthermore, some evidence indicates that virtual nature can improve attentional resources, cognitive performance, and pain experience.
This clinical trial aims to analyze the influence of VR use in patients of Intensive Care Unit (ICU). After informed the consent form, participants will be randomly into control and intervention groups. Blood pressure, heart rate, respiratory rate, oxygen saturation will be evaluated, in addition to the experience of well-being and pain immediately before and immediately after the intervention for 2 consecutive days.The hypothesis of the study is that VR will positively influence vital signs and lived experiences, which will consequently reduce the length of stay in the ICU.
Recruitment & Eligibility
- Status
- SUSPENDED
- Sex
- All
- Target Recruitment
- 212
- individuals of both sexes;
- without communication, vision, hearing or intellectual disabilities;
- capable of mental to fill in the questionnaires;
- who watch at least 5 minutes of the video, minimum physiological immersion time.
- use of sedatives;
- those who experience considerable discomfort possibly caused by virtual reality such as nausea, dizziness or headache, with a history of vertigo, nausea, vomiting;
- convulsion, labyrinthitis, epilepsy, dementia, mental confusion, psychomotor agitation;
- claustrophobia or expressing a desire to discontinue the study;
- patients who use anticholinergic drugs (antipsychotics and benzodiazepines);
- delirium;
- clinical worsening.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention Group Intervention Participants in the intervention group will use VR for 20 minutes for 2 consecutive days.
- Primary Outcome Measures
Name Time Method Change from Baseline Oxygen Saturation Percentage at post intervention. Immediately post-intervention for 2 consecutive days. Quantify the change from baseline of pulse oximetry on the monitor in the intensive care unit, immediately after the intervention on the first day of Virtual Reality use (D1) and immediately after on the second day (D2).
Change from Baseline Respiratory Rate Values at pos intervention. Immediately post-intervention for 2 consecutive days. Quantify the change from baseline of respiratory rate values on the monitor in the intensive care unit, immediately after the intervention on the first day of Virtual Reality use (D1) and immediately after on the second day (D2).
Change from Baseline Affective States pos intervention. Immediately post-intervention for 2 consecutive days. Will be applied the Positive and Negative Affect Schedule - PANAS. It is one of the most used instruments in the investigation of affective states composed of 20 questions and each item can be rated on a likert type frequency scale of sensations, raging from 0 (not at all) to 5 (extremely). The questionnaire will be applied immediately after the first day (D1) of intervention using Virtual Reality and immediately after the second day (D2).
Change from Baseline Pain Perception at pos intervention. Immediately post-intervention for 2 consecutive days. Will be applied the Visual Analogue Scale - VAS. It is one of the most used instruments for pain assessment with a score from 0 to 10 that allows the patient to evaluate the pain of the procedure through a visual analogue scale numbered from zero to ten, with zero no pain, ten being the worst pain ever felt in life.The scale will be applied immediately after the first day (D1) of intervention using Virtual Reality and immediately after the second day (D2).
Change from Baseline Blood Pressure Values at post intervention. Immediately post-intervention for 2 consecutive days. Quantify the change from baseline of blood pressure values on the monitor in the intensive care unit, immediately after the intervention on the first day of Virtual Reality use (D1) and immediately after on the second day (D2).
Change from Baseline Heart Rate Values at pos intervention. Immediately post-intervention for 2 consecutive days. Quantify the change from baseline of heart values on the monitor in the intensive care unit, immediately after the intervention on the first day of Virtual Reality use (D1) and immediately after on the second day (D2).
- Secondary Outcome Measures
Name Time Method Change in length of stay in the intensive care unit pos intervention Immediately post-intervention for 2 consecutive days. The days of hospitalization in intensive care of patients in the intervention group will be evaluated and will be compared with the days of stay in the control group.
Trial Locations
- Locations (1)
Hospital Israelita Albert Einstein
🇧🇷São Paulo, Brazil